Study of characteristics of plasma drug concentration and the possibility of drug passing through the serosa by oral administration of apatinib mesylate
Latest Information Update: 07 Oct 2020
At a glance
- Drugs Rivoceranib (Primary)
- Indications Adenocarcinoma; Cancer; Gastric cancer; Lung cancer; Small cell lung cancer
- Focus Pharmacokinetics
Most Recent Events
- 07 Oct 2020 New trial record
- 21 Sep 2020 Results presented at the 45th European Society for Medical Oncology Congress